With no new safety signals emerging in its phase 3 trials, Alumis plans to file for FDA approval in the back half of 2026. FDA approval could add to the pressure on Sotyktu, which generated $206 ...

ProLogium, a leader in solid-state battery R&D and mass production, today announced that it has signed a Memorandum of Understanding (MoU) with Delta, a global provider of power management and thermal ...

Your health should be your top priority at all times. It is the foundation for everything else that you do in life. You know ...

OXFORD, England, Jan. 6, 2026 /PRNewswire/ -- Dark Blue Therapeutics ("Dark Blue"), a discovery and development biotech company pioneering the next generation of precision oncology medicines, has been ...

California healthcare innovator Amgen, which already has facilities at Cambridge Science Park, has made a new and incisive acquisition in the UK - buying Oxford University spin-out Dark Blue ...

Pfizer could soon launch a multi-billion dollar bid for immunotherapy rivals Bristol-Myers Squibb. But moves into new fields of innovation and digital tech – such as Roche’s buyout of Flatiron - are ...

Amgen’s acquisition of Dark Blue Therapeutics adds a first-in-class leukemia program that aligns with the company’s growing ...

Many EV drivers unknowingly shorten their car's battery life. Learn which habits to unlearn if you want your electric vehicle ...

Aggregate revenue across the top 10 brokers for 2025 was just over £13bn - an amount that summed up brokerage across the ...

For the BCIA, 2025 has been a thoroughly successful and positive year. With more than 270 apprentices on its Level 4 Building ...

As electric vehicles began to appear more frequently on Vietnamese streets, many people assumed that repairing them was ...

We read with interest the article by Santacroce about personalised medicine in eosinophilic oesophagitis (EoE) and the ...